Detalhe da pesquisa
1.
Circulating CD8 lymphocytes predict response to atezolizumab-bevacizumab in hepatocellular carcinoma.
Eur J Immunol;
54(2): e2350637, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37990855
2.
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming.
J Hepatol;
72(6): 1159-1169, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31954205
3.
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival.
J Hepatol;
64(4): 891-8, 2016 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26658681
4.
Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats.
Hepatology;
61(1): 249-59, 2015 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25156012
5.
TP53/MicroRNA Interplay in Hepatocellular Carcinoma.
Int J Mol Sci;
17(12)2016 Dec 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27918441
6.
Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease.
Liver Int;
34(7): e302-7, 2014 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24313922
7.
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response.
Cancers (Basel);
16(4)2024 Feb 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38398157
8.
CDKN1C/P57 is regulated by the Notch target gene Hes1 and induces senescence in human hepatocellular carcinoma.
Am J Pathol;
181(2): 413-22, 2012 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22705236
9.
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.
Hepatology;
56(3): 1025-33, 2012 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22473819
10.
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
J Pathol;
227(3): 275-85, 2012 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22262409
11.
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab-Bevacizumab in Hepatocellular Carcinoma.
Cancers (Basel);
15(6)2023 Mar 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36980547
12.
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma.
J Exp Clin Cancer Res;
42(1): 145, 2023 Jun 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37301960
13.
MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma.
Biomolecules;
12(7)2022 07 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35883486
14.
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research.
J Hepatocell Carcinoma;
9: 1263-1278, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36523954
15.
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area.
Nutrients;
14(8)2022 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35458213
16.
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions.
J Hepatocell Carcinoma;
8: 741-757, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34239844
17.
MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma.
J Hepatocell Carcinoma;
8: 369-385, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34012928
18.
Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs.
Cells;
10(3)2021 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33804511
19.
Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating Biomarkers.
Cancers (Basel);
13(18)2021 Sep 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34572776
20.
Direct Antiviral Treatments for Hepatitis C Virus Have Off-Target Effects of Oncologic Relevance in Hepatocellular Carcinoma.
Cancers (Basel);
12(9)2020 Sep 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32961688